ING Groep »

Halozyme Therapeutics shares owned by ING Groep

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by ING Groep from 13F filings

Historical chart of ING Groep investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by ING Groep consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by ING Groep

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.7M 91k 73.34

More positions owned by ING Groep

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Bank of America Corporation (BAC)
Linde SHS (LIN)
Honeywell International (HON)
Select Sector Spdr Tr State Street Ind (XLI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
salesforce (CRM)

View all positions for ING Groep

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Alliancebernstein
Norges Bank Investment Management
William Blair Investment Management
Federated Investors
Jupiter Asset Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics